Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib Combined With SG001 in Advanced Solid Tumours
NCT05508659Phase 2Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of duvelisib in solid tumor (advanced stage), sponsored by CSPC ZhongQi Pharmaceutical Technology. Status: unknown.
02
Drugs
duvelisib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05508659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05508659.